BevCanna Enterprises

SKYE BIOSCIENCE OTCMKTSSKYE STOCK QUOTE

https://skyebioscience.com/

LATEST NEWS FROM SKYE BIOSCIENCE

Skye Bioscience Announces Special Virtual Investor Presentation

Skye Bioscience to Present at the H.C. Wainwright 23rd Annual Global Investment Conference

Skye Bioscience to Present at the H.C. Wainwright Ophthalmology Conference

Skye Bioscience Completes THCVHS IND-enabling In Vitro Genotoxicity Studies

Skye Bioscience Appoints Biotech Executive Praveen Tyle, Ph.D. to Board of Directors

Skye Bioscience Expands Clinical Advisory Board with the Appointment of Ophthalmology Expert Dr. Miguel González-Andrades

CEO Presenting on the Emerging Growth Conference on June 9. Register here

Skye Bioscience’s THCVHS Demonstrates Superior Therapeutic Benefit Compared to Glaucoma Standard of Care, both as Combination and Single Agent, in Preclinical Study

Skye Bioscience Completes CMC and GLP Production for THCVHS Lead Program

Skye Bioscience to Present at Upcoming Investment Conferences in April

Skye Bioscience to Present at Benzinga Biotech Small Cap Conference

Skye Bioscience’s Cannabinoid-Derived Drug Candidate, THCVHS, Demonstrates No Eye Irritation in Preclinical Assessment

Skye Bioscience Appoints Cannabinoid Science Experts Giovanni Appendino, PhD and Eduardo Muñoz, MD, PhD to Scientific Advisory Board

Skye Bioscience to Present at H.C. Wainwright Global Life Sciences Conference

Skye Bioscience to Participate in Investment Conferences in February